Organization Overview
Alternative names
tenapanor (Ibsrela) (2019 NDA)
Albuminuria (Phase 2)
Constipation (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Hyperkalemia (Phase 2)
Hyperphosphatemia (Phase 4)
Irritable Bowel Syndrome (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Syndrome (Phase 3)